ADR Report-ADRs slip as telecoms overshadow data
2009-08-06 15:28:00.0
Track China's Leaders
Thu, Aug 13 2009
Tue, Aug 11 2009
Mon, Aug 10 2009
Wed, Aug 5 2009
Tue, Aug 4 2009
Thu  EDT
) were off 1.8 percent to $60.65 as the Danish drugmaker reported better-than-expected second-quarter profit and raised its guidance but disappointed investors by not giving more solid news on the U.S. approval process for its new diabetes drug. For details, see [ID:nL6518356]
), down 2.1 percent to $38.16, Novartis (
), down 1.2 percent to $45.07 and AstraZeneca (
), off 2.5 percent to $45.58, lost ground after the World Health Organization said the first vaccines to combat H1N1 swine flu would be approved for use in some countries by September, although productions yields had a difficult start. [ID:nL6332419]
On the upside, China Mobile (
) jumped 7.3 percent to $56.08, helped by talk the world's largest wireless carrier may list on the mainland Chinese A-share market by the end of the year. [ID:nHKF082389]
The Bank of New York Mellon index of leading Asian ADRs .BKAS was flat. In Asia, stocks edged up close to 11-month highs on strength in resource-related shares, while the Australian dollar gained after a surprise rise in employment prompted increased bets on higher interest rates. [ID:nHKG41182]
The Bank of New York Mellon index of leading European ADRs .BKEUR dipped 1 percent. In Europe, the FTSEurofirst 300
Receipts with the Bank of New York Mellon index of leading Latin American ADRs .BKLA slid 1.8 percent. U.S.-traded shares of Mexico's largest wireless operator, America Movil (
) fell 3.3 percent to $44.30. (Reporting by Chuck Mikolajczak; Editing by Chizu Nomiyama)
